Stryker Corporation (SYK)
NYSE: SYK
· Real-Time Price · USD
377.92
3.93 (1.05%)
At close: May 02, 2025, 3:59 PM
375.97
-0.52%
Pre-market: May 05, 2025, 05:19 AM EDT
1.05% (1D)
Bid | 366.5 |
Market Cap | 144.25B |
Revenue (ttm) | 23.22B |
Net Income (ttm) | 2.86B |
EPS (ttm) | 7.74 |
PE Ratio (ttm) | 48.83 |
Forward PE | 25.19 |
Analyst | Buy |
Ask | 385.13 |
Volume | 3,264,186 |
Avg. Volume (20D) | 1,604,642.3 |
Open | 375.73 |
Previous Close | 373.99 |
Day's Range | 363.08 - 379.32 |
52-Week Range | 314.93 - 406.19 |
Beta | 0.94 |
About SYK
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and...
Industry Medical - Devices
Sector Healthcare
IPO Date Mar 17, 1980
Employees 53,000
Stock Exchange NYSE
Ticker Symbol SYK
Website https://www.stryker.com
Analyst Forecast
According to 19 analyst ratings, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $435, which is an increase of 15.10% from the latest price.
Stock ForecastsEarnings Surprise
Stryker has released their quartely earnings
on May 1, 2025:
3 days ago
+1.13%
SYK stock has given up its prior loss. Stryker sha...
Unlock content with
Pro Subscription
3 days ago
+1.13%
Stryker shares are trading lower after the company cut its FY25 adjusted EPS guidance and Evercore ISI group lowered its price target on the stock from $400 to $390.